+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Fluid Bags Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 192 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968682
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The medical fluid bags market is rapidly evolving as decision-makers tackle new demands in safety, efficiency, and product versatility. Addressing regulatory shifts and supply chain pressure, leaders face vital choices that will guide value creation and risk management across healthcare settings.

Market Snapshot: Medical Fluid Bags Market Size & Growth

The global medical fluid bags market grew from USD 2.94 billion in 2024 to USD 3.14 billion in 2025, demonstrating a strong CAGR of 6.66%. This sector is projected to reach USD 4.93 billion by 2032. Momentum is driven by accelerating clinical demands, stricter quality benchmarks, and advances in bag design. These factors are reshaping operational priorities and sustaining the market’s long-term investment potential.

Scope & Segmentation

  • Product Types: Blood bags, chemotherapy bags, parenteral nutrition bags, and saline bags. Each segment enables unique clinical applications and patient care needs, resulting in heightened demand for purpose-designed features and strict compliance requirements.
  • Material Types: Non-PVC and PVC. The adoption of non-PVC material is rising as organizations prioritize patient and environmental safety, while PVC maintains a role due to cost and proven manufacturing processes.
  • End Users: Hospitals, clinics, ambulatory centers, and home care. The spectrum of care delivery requires suppliers to engineer adaptable solutions that work from high-intensity hospital units to distributed home settings, each with distinct workflow and user experience demands.
  • Delivery Modes: Gravity and pump systems, including elastomeric, syringe, and volumetric pumps. These support a wide range of infusion protocols and address varied requirements for precision, therapy type, and patient mobility.
  • Sterilization Methods: Ethylene oxide and gamma irradiation. Both methods are central to ensuring safe, compliant, and internationally distributable products. Manufacturers align protocols with evolving global standards to maintain market entry.
  • Geographic Coverage: Americas, Europe, Middle East, Africa, and Asia-Pacific. Regional leaders such as the United States, China, Germany, India, and Brazil each present distinct procurement approaches and regulatory requirements, shaping regional competition.
  • Key Players: Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, ICU Medical, Inc., Pfizer Inc., Grifols, S.A., Vetter Pharma-Fertigung GmbH & Co. KG, Sichuan Kelun Pharmaceutical Co., Ltd., Poly Medicure Ltd., Macopharma S.A.S. Industry competition accelerates product development and fosters strategic collaboration.

Key Takeaways for Decision-Makers

  • Material innovation, especially the increased adoption of non-PVC, responds to evolving safety, compliance, and sustainability requirements, enhancing patient outcomes and reducing environmental risk.
  • Regulatory scrutiny across the market is intensifying, leading companies to adopt proactive compliance strategies and reevaluate sterilization and sourcing practices to safeguard global access.
  • Integration of technology, such as embedded sensors, provides granular usage data and clinical feedback, supporting continuous product optimization and compliance monitoring.
  • Expansion into home and ambulatory care settings drives demand for products that offer user-friendly operation and broad device compatibility, shifting purchase criteria and supplier priorities.
  • Strategic partnerships and acquisitions are increasingly centered on bolstering R&D, scaling sterilization workflows, and leveraging digital and logistics platforms to expand reach and resilience.

Tariff Impact: Navigating U.S. Duties in 2025 and Beyond

  • Recent U.S. tariffs on raw materials and finished fluid bags have disrupted cost forecasts and prompted a reevaluation of procurement and contracting strategies.
  • Organizations are pursuing measures such as long-term supplier agreements, regional sourcing, and expanded domestic polymer production to mitigate risk and reinforce supply chain buffer capacity.
  • Transparency in pricing and supply relationships will remain pivotal as providers manage increased cost variability due to upstream policy shifts.

Medical Fluid Bags Market: Key Technology Trends

  • Enhanced polymers and multilayer coextrusion techniques are delivering improved product durability, with containment performance meeting advanced clinical and operational demands.
  • Compatibility with infusion pumps and digital platforms is considered essential, particularly as remote and decentralized care take hold, further supporting data-driven product monitoring and performance analytics.
  • Focused investment in ethylene oxide and gamma irradiation sterilization helps preserve compliance with international standards and ensures readiness to respond to dynamic market regulations.

Methodology & Data Sources

This assessment draws on structured interviews with procurement leaders, clinical practitioners, and material specialists. Secondary research includes regulatory filings, technical literature, industry reports, patent reviews, and is validated through triangulation with manufacturing indices and global trade data.

Why This Report Matters

  • Enables senior executives to respond to shifting regulatory and supply chain realities in the medical fluid bags market with actionable analysis.
  • Presents explicit segmentation frameworks to inform new product planning, procurement strategy, and market entry, supporting evidence-based commercial decisions.
  • Delivers benchmarking insights into innovation and market alliances, identifying collaborative and investment opportunities in a rapidly changing competitive environment.

Conclusion

This report guides senior leaders through the interplay of regulatory change, next-generation material science, and evolving digital applications. Informed strategy and resilient operations are key for sustainable market advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Surge in home infusion therapy driving demand for lightweight portable fluid bags with integrated carrying solutions
5.2. Adoption of biodegradable polymer-based medical fluid bags to address regulatory and environmental concerns
5.3. Integration of smart sensors within fluid bags for real-time monitoring of infusion flow rate and temperature conditions
5.4. Development of multi-chamber parenteral nutrition bags to simplify complex nutritional therapy protocols in hospitals
5.5. Partnerships between medical bag manufacturers and telehealth platforms for remote infusion monitoring and data analytics
5.6. Implementation of anti-microbial surface coatings on fluid bags to prevent bacterial contamination during storage and transport
5.7. Shift towards closed system transfer devices integrated with fluid bags to minimize medication waste and exposure risks
5.8. Regulatory harmonization efforts influencing material selection and quality standards for medical fluid bag production across regions
5.9. Advancements in collapsible bag design to reduce medical waste volume and optimize hospital storage space and logistics
5.10. Deployment of AI-driven compounding automation stations for on-site preparation of personalized fluid bag therapies in hospitals
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Medical Fluid Bags Market, by Product Type
8.1. Blood Bags
8.2. Chemotherapy Bags
8.3. Parenteral Nutrition Bags
8.4. Saline Bags
9. Medical Fluid Bags Market, by Material
9.1. Non Pvc
9.2. Pvc
10. Medical Fluid Bags Market, by End User
10.1. Ambulatory Centers
10.2. Clinics
10.3. Home Care
10.4. Hospitals
11. Medical Fluid Bags Market, by Delivery Mode
11.1. Gravity
11.2. Pump
11.2.1. Elastomeric Pump
11.2.2. Syringe Pump
11.2.3. Volumetric Pump
12. Medical Fluid Bags Market, by Sterilization Method
12.1. Ethylene Oxide
12.2. Gamma
13. Medical Fluid Bags Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Medical Fluid Bags Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Medical Fluid Bags Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Fresenius Kabi AG
16.3.2. Terumo Corporation
16.3.3. Nipro Corporation
16.3.4. ICU Medical, Inc.
16.3.5. Pfizer Inc.
16.3.6. Grifols, S.A.
16.3.7. Vetter Pharma-Fertigung GmbH & Co. KG
16.3.8. Sichuan Kelun Pharmaceutical Co., Ltd.
16.3.9. Poly Medicure Ltd.
16.3.10. Macopharma S.A.S.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Medical Fluid Bags market report include:
  • Fresenius Kabi AG
  • Terumo Corporation
  • Nipro Corporation
  • ICU Medical, Inc.
  • Pfizer Inc.
  • Grifols, S.A.
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Poly Medicure Ltd.
  • Macopharma S.A.S.

Table Information